test

Aryn Sands

@Bml Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$169.95MTotal holdings29
Assets growth rate21.28%Assets growth rate (2-Q avg)6.84%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Bml Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Bml Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 169.95M in assets, with a quarterly growth rate of 21.28% and a 2-quarter average growth rate of 6.84%. The portfolio is managed by Aryn Sands, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SGOVIshares Tr
Recent Activity
16.01%
$27.194M
270,000 shares@ $100.72 avg price
TILInstil Bio Inc
Recent Activity
Decreased -14.34%
13.27%
$22.552M
335,000 shares@ $67.32 avg price
AVIRAtea Pharmaceuticals Inc
Recent Activity
Increased 4.31%
13.11%
$22.277M
6.65M shares@ $3.35 avg price
ACRSAclaris Therapeutics Inc
Recent Activity
Increased 9.72%
9.65%
$16.387M
14.25M shares@ $1.15 avg price
BILSpdr Ser Tr
Recent Activity
Decreased -12.5%
9.46%
$16.067M
175,000 shares@ $91.81 avg price
ADVMAdverum Biotechnologies Inc
Recent Activity
Increased 15.37%
9.37%
$15.922M
2.268M shares@ $7.02 avg price
TECXTectonic Therapeutic Inc
Recent Activity
Decreased -54.56%
3.78%
$6.416M
211,752 shares@ $30.31 avg price
ANTXAn2 Therapeutics Inc
Recent Activity
New Position
3.62%
$6.152M
5.749M shares@ $1.07 avg price
RPHMReneo Pharmaceuticals Inc
Recent Activity
Increased 29.39%
3.46%
$5.878M
3.457M shares@ $1.71 avg price
ORMPOramed Pharmaceuticals Inc
Recent Activity
Increased 62.06%
3.14%
$5.334M
2.186M shares@ $2.44 avg price